Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Witte

Showing results (401-410 of 409) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 409 results.
NPJ Precision Oncology|July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancerAnbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.
Cancer Cell|July 16, 2015
DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and MetastasisJonathan F Goodwin, Vishal Kothari, Justin M Drake, et al.
Science Translational Medicine|December 6, 2019
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancerYanjing Li, Yiping He, William Butler, et al.
Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.
Nature Communications|July 2, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progenyTheodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanomaThinle Chodon, Begoña Comin-Anduix, Bartosz Chmielowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2018
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune SystemCristina Puig-Saus, Giulia Parisi, Angel Garcia-Diaz, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
Cancer Research|October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate CancerMartin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Pageof 41

Showing results (401-410 of 409) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 409 results.
NPJ Precision Oncology|July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancerAnbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.
Cancer Cell|July 16, 2015
DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and MetastasisJonathan F Goodwin, Vishal Kothari, Justin M Drake, et al.
Science Translational Medicine|December 6, 2019
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancerYanjing Li, Yiping He, William Butler, et al.
Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.
Nature Communications|July 2, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progenyTheodore S Nowicki, Nataly Naser Al Deen, Cole W Peters, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanomaThinle Chodon, Begoña Comin-Anduix, Bartosz Chmielowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2018
IND-Enabling Studies for a Clinical Trial to Genetically Program a Persistent Cancer-Targeted Immune SystemCristina Puig-Saus, Giulia Parisi, Angel Garcia-Diaz, et al.
Cell Stem Cell|September 10, 2019
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for CancerYanni Zhu, Drake J Smith, Yang Zhou, et al.
Cancer Research|October 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate CancerMartin Sjöström, Shuang G Zhao, Samuel Levy, et al.
Pageof 41